Amiodarone can be used in a variety of arrhythmias. Given its widespread use, the probability of clinicians encountering its cutaneous adverse effects is high. A few cases of amiodarone-induced cutaneous vasculitis were reported in the literature, probably because it is underdiagnosed in clinical practice. Indeed, amiodarone-related cutaneous reactions may present a wide range of manifestations and are sometimes difficult to diagnose. Herein, we report a case with a sizeable necrotic ulcer on the left lower leg shortly after amiodarone exposure. A rigorous diagnostic study was performed before concluding the diagnosis of amiodarone-induced cutaneous vasculitis, which showed the histopathological features of leukocytoclastic vasculitis. The lesion was almost completely healed by the third month of discontinuation of amiodarone. We did a literature search and found seven cases which were reported as leukocytoclastic or lymphocytic vasculitis. We reviewed previous cases and presented our case in comparison to prior cases.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-022-06231-xDOI Listing

Publication Analysis

Top Keywords

amiodarone-induced cutaneous
12
leukocytoclastic vasculitis
8
cutaneous vasculitis
8
vasculitis
5
cutaneous leukocytoclastic
4
vasculitis case
4
case report
4
report review
4
review literature
4
literature amiodarone
4

Similar Publications

A Novel Strategy for the Discovery of Drug Targets: Integrating Clinical Evidence with Molecular Studies.

Biol Pharm Bull

February 2024

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University.

The mechanisms of several drugs remain unclear, limiting our understanding of how they exert their effects. Receptor affinities have not been comprehensively measured during drug development, and the safety investigations in humans are limited. Therefore, numerous unknown adverse and beneficial effects of drugs in humans persist.

View Article and Find Full Text PDF

Background: Amiodarone is one of the most commonly used and effective antiarrhythmic drugs to treat ventricular and supraventricular arrhythmias. Besides its advantages, this drug has side effects like liver, digestive, pulmonary, thyroid, neural, skin, optical, hematologic, psychiatric, and cardiac complications. Blue-gray cutaneous discoloration, also known as blue man syndrome, is an undesirable and unusual side-effect of chronic amiodarone therapy in less than 3% of patients.

View Article and Find Full Text PDF

Amiodarone can be used in a variety of arrhythmias. Given its widespread use, the probability of clinicians encountering its cutaneous adverse effects is high. A few cases of amiodarone-induced cutaneous vasculitis were reported in the literature, probably because it is underdiagnosed in clinical practice.

View Article and Find Full Text PDF

[Amiodarone-induced immune complex cutaneous vasculitis].

Ann Dermatol Venereol

December 2017

Service de dermatologie, CHU Henri-Mondor, 51, avenue du Marechal-de-Lattre-de-Tassigny, 94000 Créteil, France; EA 7379 EpiDermE, université Paris Est Créteil (UPEC), 94000 Créteil, France; Université Paris Est Créteil (UPEC), 94000 Créteil, France.

Background: A wide variety of drugs can cause cutaneous vasculitis. Herein we report a case of immune complex vasculitis induced by amiodarone.

Patients And Methods: A 57-year-old patient reported a recent history of pruritus associated with large erythematous, inflammatory, necrotic plaques localized on the lower limbs and back.

View Article and Find Full Text PDF

Persistent severe amiodarone-induced photosensitivity.

Clin Exp Dermatol

September 2005

Photobiology Unit, St John's Institute of Dermatology, St Thomas' Hospital, London, UK.

Amiodarone, a benzofuran derivative, has been used therapeutically as an antiarrhythmic and coronary vasodilator in Europe since 1964. One of its commoner side effects is cutaneous photosensitivity; more rarely, after ingestion of the drug for around 12 months, a slate-grey or violaceous discoloration of sun-exposed sites may gradually develop. Both of these side effects usually resolve within 2 years of discontinuation of the drug.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!